245 related articles for article (PubMed ID: 26032150)
1. Opioid-Induced Esophageal Dysfunction (OIED) in Patients on Chronic Opioids.
Ratuapli SK; Crowell MD; DiBaise JK; Vela MF; Ramirez FC; Burdick GE; Lacy BE; Murray JA
Am J Gastroenterol; 2015 Jul; 110(7):979-84. PubMed ID: 26032150
[TBL] [Abstract][Full Text] [Related]
2. Opioid-Induced Esophageal Dysfunction: Differential Effects of Type and Dose.
Snyder DL; Crowell MD; Horsley-Silva J; Ravi K; Lacy BE; Vela MF
Am J Gastroenterol; 2019 Sep; 114(9):1464-1469. PubMed ID: 31403963
[TBL] [Abstract][Full Text] [Related]
3. Chronic daily opioid exposure is associated with dysphagia, esophageal outflow obstruction, and disordered peristalsis.
Babaei A; Szabo A; Shad S; Massey BT
Neurogastroenterol Motil; 2019 Jul; 31(7):e13601. PubMed ID: 30993800
[TBL] [Abstract][Full Text] [Related]
4. Chronic opioid use is associated with obstructive and spastic disorders in the esophagus.
Sanchez MJ; Olivier S; Gediklioglu F; Almeida M; Gaeta M; Nigro M; de la Rosa R; Nguyen M; Lalehzari M; Regala F; Njei B; Deng Y; Ciarleglio M; Masoud A
Neurogastroenterol Motil; 2022 Mar; 34(3):e14233. PubMed ID: 34532898
[TBL] [Abstract][Full Text] [Related]
5. Opioid-induced esophageal dysfunction.
Snyder DL; Vela MF
Curr Opin Gastroenterol; 2020 Jul; 36(4):344-350. PubMed ID: 32427604
[TBL] [Abstract][Full Text] [Related]
6. Incidence of opioid-induced esophageal dysfunction.
Ladrón Abia P; Ortiz V; García-Campos M; Saéz-González E; Mínguez Sabater A; Izquierdo R; Garrigues V
Gastroenterol Hepatol; 2023 Apr; 46(4):249-254. PubMed ID: 35605820
[TBL] [Abstract][Full Text] [Related]
7. Impact of opioids on esophageal motility.
Snyder DL; Vela MF
Neurogastroenterol Motil; 2023 May; 35(5):e14587. PubMed ID: 37060333
[TBL] [Abstract][Full Text] [Related]
8. Lower prevalence of gastroesophageal reflux disease in patients with noncardiac chest pain on opiates: a cross-sectional study.
Cifuentes JDG; Thota PN; Lopez R
Dis Esophagus; 2018 Nov; 31(11):. PubMed ID: 29846541
[TBL] [Abstract][Full Text] [Related]
9. Codeine induces increased resistance at the esophagogastric junction but has no effect on motility and bolus flow in the pharynx and upper esophageal sphincter in healthy volunteers: A randomized, double-blind, placebo-controlled, cross-over trial.
Geeraerts A; Geysen H; Ballet L; Hofmans C; Clevers E; Omari T; Manolakis AC; Mols R; Augustijns P; Vanuytsel T; Rommel N; Tack J; Pauwels A
Neurogastroenterol Motil; 2021 May; 33(5):e14041. PubMed ID: 33232555
[TBL] [Abstract][Full Text] [Related]
10. Esophagogastric junction outflow obstruction is often associated with coexistent abnormal esophageal body motility and abnormal bolus transit.
Zheng E; Gideon RM; Sloan J; Katz PO
Dis Esophagus; 2017 Oct; 30(10):1-4. PubMed ID: 28859391
[TBL] [Abstract][Full Text] [Related]
11. Opioid-induced esophageal dysfunction - Prevalence and manometric findings.
Alcalá-González LG; Jiménez-Masip A; Relea Pérez L; Barber-Caselles C; Barba-Orozco E
Rev Esp Enferm Dig; 2022 Jan; 114(1):16-21. PubMed ID: 33486967
[TBL] [Abstract][Full Text] [Related]
12. Characterization and follow-up of esophagogastric junction outflow obstruction detected by high resolution manometry.
Pérez-Fernández MT; Santander C; Marinero A; Burgos-Santamaría D; Chavarría-Herbozo C
Neurogastroenterol Motil; 2016 Jan; 28(1):116-26. PubMed ID: 26517978
[TBL] [Abstract][Full Text] [Related]
13. Opiate-induced oesophageal dysmotility.
Kraichely RE; Arora AS; Murray JA
Aliment Pharmacol Ther; 2010 Mar; 31(5):601-6. PubMed ID: 20003176
[TBL] [Abstract][Full Text] [Related]
14. The Chicago Classification of esophageal motility disorders, v3.0.
Kahrilas PJ; Bredenoord AJ; Fox M; Gyawali CP; Roman S; Smout AJ; Pandolfino JE;
Neurogastroenterol Motil; 2015 Feb; 27(2):160-74. PubMed ID: 25469569
[TBL] [Abstract][Full Text] [Related]
15. The Chicago classification of motility disorders: an update.
Roman S; Gyawali CP; Xiao Y; Pandolfino JE; Kahrilas PJ
Gastrointest Endosc Clin N Am; 2014 Oct; 24(4):545-61. PubMed ID: 25216902
[TBL] [Abstract][Full Text] [Related]
16. Effects of remifentanil on esophageal and esophagogastric junction (EGJ) bolus transit in healthy volunteers using novel pressure-flow analysis.
Cock C; Doeltgen SH; Omari T; Savilampi J
Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28833926
[TBL] [Abstract][Full Text] [Related]
17. Anticholinergic, anti-depressant and other medication use is associated with clinically relevant oesophageal manometric abnormalities.
Moosavi S; Woo M; Jacob DA; Pradhan S; Wilsack L; Buresi M; Gupta M; Al-Awadh Y; Li D; Andrews CN
Aliment Pharmacol Ther; 2020 Jun; 51(11):1130-1138. PubMed ID: 32383253
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic Approach for Esophagogastric Junction Outflow Obstruction].
Cho YK
Korean J Gastroenterol; 2020 Oct; 76(4):179-184. PubMed ID: 33100312
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic interrogation of patients with esophagogastric junction outflow obstruction using amyl nitrite.
Babaei A; Shad S; Szabo A; Massey BT
Neurogastroenterol Motil; 2019 Sep; 31(9):e13668. PubMed ID: 31236998
[TBL] [Abstract][Full Text] [Related]
20. Same-day opioid administration in opiate naïve patients is not associated with opioid-induced esophageal dysfunction (OIED).
Balko RA; Katzka DA; Murray JA; Alexander JA; Mara KC; Ravi K
Neurogastroenterol Motil; 2021 May; 33(5):e14059. PubMed ID: 33350541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
